These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1861081

  • 1. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives.
    Masaki T, Matsumoto M, Yasuda R, Levine RP, Kitamura H, Seya T.
    J Immunol; 1991 Aug 01; 147(3):927-32. PubMed ID: 1861081
    [Abstract] [Full Text] [Related]

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 3. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
    Masaki T, Matsumoto M, Hara T, Nakanishi I, Kitamura H, Seya T.
    Mol Immunol; 1995 Jan 01; 32(1):21-6. PubMed ID: 7870055
    [Abstract] [Full Text] [Related]

  • 4. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO, Jaikaran AS, Carroll MC, Anderson MJ, Campbell RD, Isenman DE.
    J Immunol; 1992 May 01; 148(9):2803-11. PubMed ID: 1573269
    [Abstract] [Full Text] [Related]

  • 5. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul 01; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 6. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM, Colomb MG.
    Eur J Immunol; 1986 Jun 01; 16(6):617-22. PubMed ID: 3487454
    [Abstract] [Full Text] [Related]

  • 7. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
    Ebanks RO, Isenman DE.
    J Immunol; 1995 Mar 15; 154(6):2808-20. PubMed ID: 7876551
    [Abstract] [Full Text] [Related]

  • 9. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar 01; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 11. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 13. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.
    Biochemistry; 2009 Sep 08; 48(35):8466-72. PubMed ID: 19642650
    [Abstract] [Full Text] [Related]

  • 14. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.
    Reilly BD, Levine RP, Skanes VM.
    J Immunol; 1991 Nov 01; 147(9):3018-23. PubMed ID: 1919003
    [Abstract] [Full Text] [Related]

  • 15. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P, Joiner KA, Hammer CH, Frank MM, Tosi R.
    J Immunol; 1987 May 15; 138(10):3385-91. PubMed ID: 2952716
    [Abstract] [Full Text] [Related]

  • 16. The binding of human complement component C4 to antibody-antigen aggregates.
    Campbell RD, Dodds AW, Porter RR.
    Biochem J; 1980 Jul 01; 189(1):67-80. PubMed ID: 6906229
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 01; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 18. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 19. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
    Loos M, Heinz HP.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Nov 01; 284():67-74. PubMed ID: 6375257
    [Abstract] [Full Text] [Related]

  • 20. Covalent linkage of C3 to properdin during complement activation.
    Whiteman LY, Purkall DB, Ruddy S.
    Eur J Immunol; 1995 May 01; 25(5):1481-4. PubMed ID: 7774654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.